Peginterferon and Dacryoadenitis acquired - from FDA reports


Dacryoadenitis acquired is reported only by a few people who take Peginterferon. We study 12,519 people who have side effects while taking Peginterferon from FDA. Among them, 2 have Dacryoadenitis acquired. Find out below who they are, when they have Dacryoadenitis acquired and more.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 02, 2018

12,519 people reported to have side effects when taking Peginterferon.
Among them, 2 people (0.02%) have Dacryoadenitis acquired


Number of reports submitted per year:

Could Peginterferon cause Dacryoadenitis acquired?

Gender of people who have Dacryoadenitis acquired when taking Peginterferon *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Dacryoadenitis acquired when taking Peginterferon *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  1. Hyperthyroidism (over activity of the thyroid gland): 2 people, 100.00%
  2. High Blood Pressure: 2 people, 100.00%
Check whether a drug or a condition causes Dacryoadenitis acquired

Top co-used drugs for these people *:

  1. Ribavirin: 2 people, 100.00%
Subscribe to monitor Dacryoadenitis acquired in Peginterferon

Top other side effects for these people *:

  1. Tenderness (pain or discomfort when an affected area is touched): 2 people, 100.00%
  2. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 100.00%
  3. Rashes (redness): 2 people, 100.00%
  4. Night Sweats (sweating in night): 2 people, 100.00%
  5. Joint Pain: 2 people, 100.00%
  6. Gamma-Glutamyltransferase Increased: 2 people, 100.00%
  7. Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 100.00%
  8. Eye Irritation: 2 people, 100.00%
  9. Erythema Nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below): 2 people, 100.00%
  10. Aspartate Aminotransferase Increased: 2 people, 100.00%
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Peginterferon or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Peginterferon

Peginterferon has active ingredients of peginterferon alfa-2a; ribavirin. It is often used in hepatitis c. (latest outcomes from Peginterferon 12,608 users)

Dacryoadenitis acquired

Dacryoadenitis acquired (inflammation of the lacrimal glands acquired) has been reported by people with hepatitis c, high blood pressure, hyperthyroidism, rheumatoid arthritis, sialoadenitis (latest reports from 28 Dacryoadenitis acquired patients).


Drugs that are associated with Dacryoadenitis acquired
Dacryoadenitis acquired (25 drugs)
Could your condition cause Dacryoadenitis acquired
Dacryoadenitis acquired (21 conditions)
Peginterferon side effects
Browse all side effects of Peginterferon
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Peginterferon and have Dacryoadenitis acquired


You are not alone. Join our personalized support groups:


Recent updates

General studies

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.